Turn Therapeutics Inc. (TTRX) Form 10-Q Quarterly Reports
Turn Therapeutics Inc. (TTRX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TTRX
CIK: 2023016
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerZachary NewComer
Audit LocationWhippany, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-07 | 2026-10-06 | CURRENT REPORT | 0001213900-26-107329 | View SEC Doc Filr Page |
| 8-K | 2026-09-10 | 2026-09-10 | CURRENT REPORT | 0001213900-26-098584 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | CURRENT REPORT | 0001213900-26-098224 | View SEC Doc Filr Page |
| D | 2026-08-26 | — | D Filing | 0002023016-26-000001 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-13 | CURRENT REPORT | 0001213900-26-091002 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | CURRENT REPORT | 0001213900-26-090766 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-088427 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | CURRENT REPORT | 0001213900-26-088411 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | CURRENT REPORT | 0001213900-26-081996 | View SEC Doc Filr Page |
| 8-K | 2026-07-07 | 2026-07-07 | CURRENT REPORT | 0001213900-26-075757 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001213900-26-066395 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001213900-26-066394 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001213900-26-066393 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | 4 Filing | 0001213900-26-066391 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | CURRENT REPORT | 0001213900-26-064405 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-28 | 4 Filing | 0001213900-26-063629 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-06-01 | CURRENT REPORT | 0001213900-26-063177 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | CURRENT REPORT | 0001213900-26-061244 | View SEC Doc Filr Page |
| 8-K | 2026-05-19 | 2026-05-19 | CURRENT REPORT | 0001213900-26-058730 | View SEC Doc Filr Page |
| 8-K | 2026-05-18 | 2026-05-18 | CURRENT REPORT | 0001213900-26-058140 | View SEC Doc Filr Page |
| C-TR | 2026-05-13 | — | C-TR Filing | 0001213900-26-055361 | View SEC Doc Filr Page |
| 10-Q | 2026-05-11 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-054490 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | CURRENT REPORT | 0001213900-26-054480 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-06 | — | SCHEDULE 13G Filing | 0001213900-26-040158 | View SEC Doc Filr Page |
| 4 | 2026-04-03 | 2026-04-02 | 4 Filing | 0001213900-26-039715 | View SEC Doc Filr Page |